Business
DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District
TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is pleased to announce the strategic acquisition of claims located adjacent to Quebec Innovative Materials Corp. (“QIMC”) (CSE: QIMC) (OTCQB: QIMCF), comprising 91 unpatented, single-cell mineral claims, each cell approximately 20 hectares in size, totaling an area of 1820 hectares,
About this update from Quebec Innovative Materials Corp
[{"type":"image","alt":"DiagnaMed Holdings Corp.","displaySize":"","headline":null,"caption":"DiagnaMed Holdings Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":160,"url":"https://media.zenfs.com/en/globenewswire.com/23f2c7160a854bd2678f038048700708"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZoYFoRn__IbgLfnINayW_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyNDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/23f2c7160a854bd2678f038048700708","width":300,"height":160}},"lazy":false},{"type":"text","content":"TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is pleased to announce the strategic acquisition of claims located adjacent to Quebec Innovative Materials Corp. (“QIMC”) (CSE: QIMC) (OTCQB: QIMCF), comprising 91 unpatented, single-cell mineral claims, each cell approximately 20 hectares in size, totaling an area of 1820 hectares, within Ontario’s highly prospective Temiscamingue hydrogen district and graben. This acquisition positions DiagnaMed prominently within one of Canada's most promising natural hydrogen regions, providing an ideal environment to advance testing, validation, and commercialization of the Company’s proprietary hydrogen extraction technologies and exploration model.","length":867,"tagName":"p"},{"type":"text","content":"The newly acquired claims are situated directly adjacent to QIMC’s project area, allowing for operational synergies and technical collaboration. The Temiscamingue region is widely recognized for its favorable geological conditions conducive to substantial natural hydrogen generation, offering significant potential for DiagnaMed’s technology validation and commercial development.","length":381,"tagName":"p"},{"type":"text","content":"Under the terms of the acquisition agreement, the Company is required to make a non-refundable $25,000 payment and issue twelve million five hundred thousand common shares to the sellers in exchange for the Temiscamingue project. In addition, DiagnaMed has granted certain sellers a 2.0-per-cent royalty on revenues from the sale of any hydrogen or other minerals on the property. Fifty per cent of the seller royalty may be purchased for $2 million.","length":450,"tagN...